文献速递肝胆胰外科胃肠外科

前入路与传统肝切除术治疗结直肠癌肝转移的随机临床试验

Anterior Approach vs Conventional Hepatectomy for Resection of Colorectal Liver Metastasis: A Randomized Clinical Trial.
PubMed 文献 · JAMA Surg · 2021-01-01

该随机临床试验纳入80例结直肠癌肝转移患者,1:1分配至前入路或传统肝切除术,比较术中循环肿瘤细胞检测及预后。

要点

  • 前入路并未降低术中肿瘤细胞播散,CTC检出率与传统组相当。
  • 前入路手术时间显著长于传统组,但并发症和死亡率无差异。
  • CTC检出与较差的总生存和无病生存相关,但术式不影响长期生存。

核心结论

  • 前入路在减少结直肠癌肝转移切除术中肿瘤细胞播散方面不优于传统肝切除术。

研究设计与样本

  • 随机临床试验,2003年2月1日至2012年3月31日单中心纳入80例成人结直肠癌肝转移患者,1:1随机分组,意向性分析。

临床怎么用

  • 前入路不应常规用于降低结直肠癌肝转移术中肿瘤播散,术式选择可基于技术考量。
  • 术中CTC检测可能有助于预后分层,但需进一步验证。

局限性

  • 样本量较小(80例),CTC分析仅部分患者(传统组21例,前入路组22例)。
  • 单中心研究,结果外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Tumor relapse after partial hepatectomy for colorectal liver metastasis (CRLM) remains an unsolved issue. Intraoperative manipulation of the liver during conventional hepatectomy might enhance hematogenous tumor cell spread. The anterior approach is an alternative approach that may reduce intraoperative tumor cell dissemination. OBJECTIVE: To determine the efficacy and safety of the anterior approach compared with conventional hepatectomy in patients undergoing resection for CRLM. DESIGN, SETTING, AND PARTICIPANTS: This randomized clinical study evaluated the efficacy and safety of the anterior approach compared with conventional hepatectomy in adult patients with CRLM who were scheduled for hepatectomy from February 1, 2003, to March 31, 2012, at a tertiary-care hospital. A total of 80 patients with CRLM were randomized to the anterior approach and conventional hepatectomy groups in a 1:1 ratio. Bone marrow and blood samples were analyzed for disseminated tumor cells and circulating tumor cells (CTC) using cytokeratin 20 reverse transcriptase-polymerase chain reaction analysis. Data were analyzed from April 1 to December 1, 2018, using intention to treat. INTERVENTIONS: Anterior approach vs conventional hepatectomy. MAIN OUTCOMES AND MEASURES: The primary end point was intraoperative CTC detection in central blood samples after liver resection. Secondary end points included postoperative morbidity, mortality, and long-term survival. RESULTS: Among the 80 patients included in the analysis (48 men [60%]; mean [SD] age, 61 [10] years), baseline characteristics, including preoperative CTC detection, were comparable between both groups. There was no statistically significant difference in intraoperative CTC detection between patients in the conventional hepatectomy (5 of 21 [24%]) and anterior approach (6 of 22 [27%]) groups (P = .54). Except for a longer operating time in the anterior approach group (mean [SD], 171 [53] vs 221 [53] minutes; P < .001), there were no significant differences in intraoperative and postoperative outcomes between both study groups. Although detection of CTC was associated with poor overall (median, 46 [95% CI, 40-52] vs 81 [95% CI, 54-107] months; P = .03) and disease-free (median, 40 [95% CI, 34-46] vs 60 [95% CI, 46-74] months; P = .04) survival, there was no significant difference in overall (median, 73 [95% CI, 42-104] vs 55 [95% CI, 35-75] months; P = .43) and disease-free (median, 48 [95% CI, 40-56] vs 40 [95% CI, 28-52] months; P = .88) survival between the conventional hepatectomy and anterior approach groups. Also, there was no significant difference in patterns of recurrence between both groups. CONCLUSIONS AND RELEVANCE: This randomized clinical trial found that the anterior approach was not superior to conventional hepatectomy in reducing intraoperative tumor cell dissemination in patients undergoing resection of CRLM. TRIAL REGISTRATION: isrctn.org Identifier: ISRCTN45066244.

来源:JAMA Surg,查看原文。版权归原作者所有。

引用

  1. Rahbari NN, Birgin E, Bork U, et al. Anterior Approach vs Conventional Hepatectomy for Resection of Colorectal Liver Metastasis: A Randomized Clinical Trial. JAMA Surg. 2021. PMID: 33147332. doi:10.1001/jamasurg.2020.5050

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。